Relmada Therapeutics Inc Working Capital to Net Assets Ratio
Relmada Therapeutics Inc working capital to net assets ratio. Relmada Therapeutics Inc (RLMD) has a Working Capital to Net Assets ratio of 101.7% as of March 2026. Working capital of $222.45 Million (current assets of $235.34 Million minus current liabilities of $12.89 Million) is measured against net assets of $218.73 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Relmada Therapeutics Inc (2012–2025)
Working capital to net assets ratio of Relmada Therapeutics Inc from 2012 to 2025. This chart shows how Relmada Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 15 annual periods from 2012 to 2025. As of March 2026, the ratio stands at 101.7%, reflecting working capital of $222.45 Million against net assets of $218.73 Million USD. Explore Relmada Therapeutics Inc (RLMD) investment intensity to see how much of total assets are deployed in long-term investments.
Relmada Therapeutics Inc Working Capital to Net Assets Ratio by Year (2012–2025)
Relmada Therapeutics Inc working capital to net assets ratio by year from 2012 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Relmada Therapeutics Inc from 2012 to 2025, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see RLMD current and non-current assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 101.2% | $87.55 Million | $86.51 Million | $93.98 Million | $6.43 Million | ▲ +1.3 pp |
| 2024 | 100.0% | $35.50 Million | $35.52 Million | $45.80 Million | $10.29 Million | ▲ +0.0 pp |
| 2023 | 99.9% | $85.31 Million | $85.36 Million | $97.51 Million | $12.19 Million | ▼ 0.0 pp |
| 2022 | 100.0% | $140.40 Million | $140.44 Million | $152.87 Million | $12.47 Million | ▼ 0.0 pp |
| 2021 | 100.0% | $208.24 Million | $208.26 Million | $223.30 Million | $15.06 Million | ▲ +0.1 pp |
| 2020 | 99.9% | $105.47 Million | $105.58 Million | $118.07 Million | $12.60 Million | ▲ +0.1 pp |
| 2019 | 99.8% | $115.48 Million | $115.68 Million | $116.94 Million | $1.46 Million | ▲ +42.4 pp |
| 2018 | 57.4% | $-3.17 Million | $-5.51 Million | $2.74 Million | $5.90 Million | ▼ -17.8 pp |
| 2017 | 75.2% | $1.10 Million | $1.46 Million | $2.47 Million | $1.38 Million | ▼ -13.4 pp |
| 2016 | 88.6% | $6.24 Million | $7.04 Million | $9.30 Million | $3.06 Million | ▼ -6.6 pp |
| 2015 | 95.2% | $8.39 Million | $8.81 Million | $23.97 Million | $15.58 Million | ▲ +0.0 pp |
| 2014 | 95.2% | $8.39 Million | $8.81 Million | $23.97 Million | $15.58 Million | ▲ +2.2 pp |
| 2014 | 93.0% | $-1.03 Million | $-1.11 Million | $25.74 Million | $26.77 Million | ▲ +0.0 pp |
| 2013 | 93.0% | $-1.03 Million | $-1.11 Million | $25.74 Million | $26.77 Million | ▼ -7.0 pp |
| 2012 | 100.0% | $11.36K | $11.36K | $18.35K | $7.00K | — |